CymitQuimica logo
BTK

BTK

Los inhibidores de la tirosina quinasa de Bruton (BTK) son compuestos que específicamente se dirigen e inhiben la BTK, una enzima crucial involucrada en la señalización del receptor de células B y en la regulación de la angiogénesis. La BTK desempeña un papel significativo en la proliferación y supervivencia de las células cancerosas, particularmente en las malignidades hematológicas. Al inhibir la BTK, estos compuestos pueden interrumpir la angiogénesis y el crecimiento tumoral, lo que los convierte en valiosos en la terapia contra el cáncer. En CymitQuimica, ofrecemos una gama de inhibidores de BTK de alta calidad para apoyar su investigación en oncología, inmunología y angiogénesis.

Se han encontrado 161 productos de "BTK"

Ordenar por

Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
productos por página.
  • TLT8


    TLT8 is a ByeTAC protein degrader that targets BTK. It induces BTK degradation by non-covalently binding to Rpn-13 and BTK. TLT8 is applicable in research on chronic lymphocytic leukemia.
    Forma y color:Odour Solid
  • Ibrutinib-biotin

    CAS:
    <p>Ibrutinib-biotin probe links Ibrutinib to biotin, with IC50 0.755-1.02 nM for BTK (patent WO2014059368A1).</p>
    Fórmula:C56H80N12O9S
    Pureza:98%
    Forma y color:Solid
    Peso molecular:1097.39
  • PROTAC BTK Degrader-11

    CAS:
    PROTAC BTK Degrader-11 is a PROTAC degrader that targets and degrades BTK with a DC50 of 1.7 nM. It is utilized in oncological research.
    Fórmula:C48H55N11O4
    Forma y color:Solid
    Peso molecular:850.02
  • PROTAC BTK Degrader-1

    CAS:
    <p>Potent, selective oral PROTAC BTK Degrader-1; IC50: 34.51 nM (WT), 64.56 nM (BTK-481S); reduces BTK protein, inhibits tumors.</p>
    Fórmula:C43H43N9O4
    Forma y color:Solid
    Peso molecular:749.86
  • GBD-9

    CAS:
    GBD-9, a dual-mechanism degrader, effectively promotes the degradation of BTK and GSPT1 through recruitment of E3 ligase cereblon (CRBN).
    Fórmula:C44H47N9O6
    Pureza:98%
    Forma y color:Solid
    Peso molecular:797.9
  • BTK-IN-5

    CAS:
    <p>BTK-IN-5 is a covalent inhibitor of Bruton's tyrosine kinase (BTK) designed for the treatment of medical conditions including cardiovascular diseases,</p>
    Fórmula:C23H32N4O5
    Forma y color:Solid
    Peso molecular:444.532
  • PCI-33380

    CAS:
    PCI-33380 is an irreversible inhibitor of Bruton's Tyrosine Kinase.
    Fórmula:C46H52BF2N11O3
    Pureza:98%
    Forma y color:Solid
    Peso molecular:855.8
  • PROTAC BTK Degrader-9


    PROTACBTK Degrader-9 (compound 23) is a potent PROTACs degrader that specifically targets BTK. It effectively downregulates the RANKL-activated BTK-PLCγ2-Ca2+-NFATc1 signaling pathway. Consequently, PROTACBTK Degrader-9 inhibits osteoclastogenesis and reduces alveolar bone resorption in a mouse model of periodontitis.
    Fórmula:C46H52FN13O5
    Peso molecular:885.41984
  • BIIB091

    CAS:
    BIIB091 is a highly selective, reversible BTK inhibitor for treating autoimmune diseases.
    Fórmula:C28H34N10O2
    Forma y color:Solid
    Peso molecular:542.648
  • BCPyr

    CAS:
    BCPyr is a new candidate BTK degrader ( DC 50 = 800 nM).
    Fórmula:C58H65F2N11O8
    Forma y color:Solid
    Peso molecular:1082.224
  • CNX-500

    CAS:
    CNX-500: covalent Btk inhibitor linked to biotin, IC50 0.5 nM, low effect on EGFR and Src kinases.
    Fórmula:C48H68N10O9S
    Pureza:98%
    Forma y color:Solid
    Peso molecular:961.18
  • PROTAC BTK Degrader-2

    CAS:
    PROTAC BTK Degrader-2, a potent degrader of BTK through the PROTAC mechanism, effectively diminishes BTK protein levels [1].
    Fórmula:C47H54F2N8O13
    Forma y color:Solid
    Peso molecular:976.97
  • PROTAC BTK Degrader-8


    PROTACBTK Degrader-8 (compound 3) is an efficient PROTAC BTK degrader with a linker that can couple with ADC antibodies to form PAC.
    Fórmula:C80H94F2N14O20P2
    Peso molecular:1670.62121
  • FDU73


    <p>FDU73 is a potent and selective BTK PROTAC degrader with a DC50 of 2.9 nM in JeKo-1 cells. It inhibits tumor cell proliferation and exhibits antitumor activity.</p>
    Forma y color:Odour Solid
  • Tyrosinase-IN-16

    CAS:
    Tyrosinase-IN-16 inhibited tyrosinase.
    Fórmula:C8H6BrN3S
    Pureza:99.94%
    Forma y color:Solid
    Peso molecular:256.12
  • PTD10

    CAS:
    PTD10, a highly potent PROTAC BTK degrader, exhibits a DC50 of 0.5 nM and a KD of 2.28 nM.
    Fórmula:C49H51N11O8
    Pureza:99.12%
    Forma y color:Solid
    Peso molecular:922
  • BRK inhibitor P21d hydrochloride

    CAS:
    BRK inhibitor P21d HCl targets breast tumor kinase with 30 nM IC50, suppresses p-SAM68 at 52 nM, useful for in vivo breast cancer research.
    Fórmula:C23H23ClFN7O2
    Forma y color:Solid
    Peso molecular:483.93
  • BTK ligand-14


    BTKligand-14 is a PROTAC-targeting ligand for BTK, suitable for the synthesis of FDU73.
    Forma y color:Odour Solid
  • BTK inhibitor 17

    CAS:
    BTK inhibitor 17 is a potent irreversible BTK inhibitor (IC50 = 2.1 nM). BTK inhibitor 17 can be used in rheumatoid arthritis studies.
    Fórmula:C25H24N6O3
    Pureza:99.57% - 99.88%
    Forma y color:Solid
    Peso molecular:456.5
  • evobrutinib

    CAS:
    Evobrutinib(M2951) , also known as M-2951 and MSC-2364447C, is a highly selective inhibitor of the Bruton's tyrosine kinase (BTK), which is important in the
    Fórmula:C25H27N5O2
    Pureza:98.03% - 99.58%
    Forma y color:Solid
    Peso molecular:429.51